Impact of Lofexidine on Stress, Craving and Opioid Use

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

June 26, 2019

Primary Completion Date

January 30, 2024

Study Completion Date

January 30, 2024

Conditions
Opioid-use DisorderOpiate Dependence
Interventions
DRUG

Lofexidine

Lofexidine, sold under the brand name Lucemyra among others, is a medication historically used to treat high blood pressure, but more commonly used to help with the physical symptoms of opioid withdrawal. It is taken by mouth. It is an α2A adrenergic receptor agonist.

DRUG

Placebo

Placebo comparator.

Trial Locations (1)

29403

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Medical University of South Carolina

OTHER

NCT03718065 - Impact of Lofexidine on Stress, Craving and Opioid Use | Biotech Hunter | Biotech Hunter